Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Mol Sci ; 25(10)2024 May 16.
Article in English | MEDLINE | ID: mdl-38791476

ABSTRACT

Critical illness and sepsis may cause organ failure and are recognized as mortality drivers in hospitalized patients. Neuropilin-1 (NRP-1) is a multifaceted transmembrane protein involved in the primary immune response and is expressed in immune cells such as T and dendritic cells. The soluble form of NRP-1 (sNRP-1) acts as an antagonist to NRP-1 by scavenging its ligands. The aim of this study was to determine the value of sNRP-1 as a biomarker in critical illness and sepsis. We enrolled 180 critically ill patients admitted to a medical intensive care unit and measured serum sNRP-1 concentrations at admission, comparing them to 48 healthy individuals. Critically ill and septic patients showed higher levels of sNRP-1 compared to healthy controls (median of 2.47 vs. 1.70 nmol/L, p < 0.001). Moreover, sNRP-1 was also elevated in patients with sepsis compared to other critical illness (2.60 vs. 2.13 nmol/L, p = 0.01), irrespective of disease severity or organ failure. In critically ill patients, sNRP-1 is positively correlated with markers of kidney and hepatic dysfunction. Most notably, critically ill patients not surviving in the long term (one year after admission) showed higher concentrations of sNRP-1 at the time of ICU admission (p = 0.036), with this association being dependent on the presence of organ failure. Critically ill and septic patients exhibit higher serum concentrations of circulating sNRP-1, which correlates to organ failure, particularly hepatic and kidney dysfunction.


Subject(s)
Biomarkers , Critical Illness , Multiple Organ Failure , Neuropilin-1 , Sepsis , Humans , Sepsis/mortality , Sepsis/blood , Male , Female , Neuropilin-1/metabolism , Neuropilin-1/blood , Middle Aged , Aged , Biomarkers/blood , Multiple Organ Failure/blood , Multiple Organ Failure/mortality , Multiple Organ Failure/etiology , Adult , Intensive Care Units , Case-Control Studies
2.
Diabetes Metab Res Rev ; 39(8): e3704, 2023 11.
Article in English | MEDLINE | ID: mdl-37553983

ABSTRACT

BACKGROUND: Besides its established impact on bone and mineral metabolism, it was suggested that fibroblast growth factor 23 (FGF23) might play an important role in the pathogenesis of type 2 diabetes. The impact of FGF23 on gestational diabetes mellitus (GDM), however, is not well understood. iFGF23 ELISAs measure the intact FGF23 molecule, whereas cFGF23 assays measure intact FGF23 as well as degradation products of FGF23. OBJECTIVES: The aim of this study is to compare the association of maternal and foetal cFGF23 and iFGF23 with GDM in a German birth cohort. METHODS: cFGF23 and iFGF23 were analysed in 826 random mother/child pairs from the Berlin Birth Cohort. RESULTS: Mothers who developed GDM had higher concentrations of iFGF-23 compared to mothers who did not suffer from GDM (19.73 vs. 13.23 pg/mL, p < 0.0001), but not higher concentrations of cFGF-23. Multivariant regression analyses showed that gestational diabetes is associated with iFGF23 independently of confounding factors such as age, BMI, ethnic background, family history of diabetes, smoking during pregnancy, and recurrent pregnancy loss. This, however, was only seen when using an iFGF23 ELISA measuring just the full length FGF23 and not in addition FGF23 fragments. No differences in both iFGF23 and cFGF23 concentrations between the GDM and non-GDM groups were detected in cord blood samples of the offspring. CONCLUSIONS: This study of a representative German birth cohort showed that maternal but not foetal iFGF23 is independently associated with GDM.


Subject(s)
Diabetes Mellitus, Type 2 , Diabetes, Gestational , Child , Female , Humans , Pregnancy , Diabetes Mellitus, Type 2/etiology , Enzyme-Linked Immunosorbent Assay , Fibroblast Growth Factor-23 , Fibroblast Growth Factors/metabolism
3.
FASEB J ; 34(11): 15269-15281, 2020 11.
Article in English | MEDLINE | ID: mdl-32964520

ABSTRACT

Fibroblast growth factor 23 (FGF23) and parathyroid hormone (PTH) are regulators of renal phosphate excretion and vitamin D metabolism. In chronic kidney disease (CKD), circulating FGF23 and PTH concentrations progressively increase as renal function declines. Oxidation of PTH at two methionine residues (positions 8 and 18) causes a loss of function. The impact of n-oxPTH and oxPTH on FGF23 synthesis, however, and how n-oxPTH and oxPTH concentrations are affected by CKD, is yet unknown. The effects of oxidized and non-oxidized PTH 1-34 on Fgf23 gene expression were analyzed in UMR106 osteoblast-like cells. Furthermore, we investigated the relationship between n-oxPTH and oxPTH, respectively, with FGF23 in two independent patients' cohorts (620 children with CKD and 600 kidney transplant recipients). While n-oxPTH stimulated Fgf23 mRNA synthesis in vitro, oxidation of PTH in particular at Met8 led to a markedly weaker stimulation of Fgf23. The effect was even stronger when both Met8 and Met18 were oxidized. In both clinical cohorts, n-oxPTH-but not oxPTH-was significantly associated with FGF23 concentrations, independent of known confounding factors. Moreover, with progressive deterioration of kidney function, intact PTH (iPTH) and oxPTH increased substantially, whereas n-oxPTH increased only moderately. In conclusion, n-oxPTH, but not oxPTH, stimulates Fgf23 gene expression. The increase in PTH with decreasing GFR is mainly due to an increase in oxPTH in more advanced stages of CKD.


Subject(s)
Fibroblast Growth Factors/metabolism , Glomerular Filtration Rate , Osteoblasts/pathology , Parathyroid Hormone/chemistry , Parathyroid Hormone/metabolism , Renal Insufficiency, Chronic/pathology , Adolescent , Animals , Child , Female , Fibroblast Growth Factor-23 , Fibroblast Growth Factors/genetics , Humans , Male , Osteoblasts/metabolism , Oxidation-Reduction , Prospective Studies , Rats , Renal Insufficiency, Chronic/genetics , Renal Insufficiency, Chronic/metabolism
4.
Mutat Res ; 565(2): 105-12, 2005 Jan 03.
Article in English | MEDLINE | ID: mdl-15661608

ABSTRACT

Multifunctional effects of flavonoids are reported to be markedly connected with their structure and the functional groups in the molecule. The important role in the activity play C2-C3 double bond, hydroxyl group at C3 and the number of hydroxyl groups at phenyl ring (B). In this paper, the DNA protective free radical scavenging potential of quercetin (QU) and luteolin (LU) against H2O2 and their clastogenic effect alone and in combination with melphalan (MH) were investigated in human melanoma HMB-2 cells. Elevated frequency of chromosomal aberrations induced by MH, that at high doses have shown a variety of toxic side effects, was statistically decreased by studied flavonoids regarding to control (QU at the concentration of 50 microM and LU already at the concentration of 20 microM). The results concerning DNA protective potential against free radicals in HMB-2 cells demonstrated that QU and LU have significant effect in dose dependent manner. The percentage of QU protective effect is 40% at the concentration 20 microM, resp. 80% at the concentration 100 microM. Comparable values were obtained with LU. Results are correlated to their structural arrangement and organization of the hydroxyl groups.


Subject(s)
DNA/drug effects , Free Radical Scavengers/pharmacology , Luteolin/pharmacology , Melanoma/metabolism , Quercetin/pharmacology , Animals , Antineoplastic Agents, Alkylating/pharmacology , Antioxidants/metabolism , Cell Line, Tumor , Chromosome Aberrations/drug effects , Comet Assay , Free Radical Scavengers/chemistry , Free Radical Scavengers/metabolism , Humans , Hydrogen Peroxide/pharmacology , Luteolin/chemistry , Luteolin/toxicity , Melphalan/pharmacology , Molecular Structure , Oxidants/pharmacology , Quercetin/chemistry , Quercetin/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...